Ventures
Browse a selection of current and former i-lab ventures.
-
All
16
-
Harvard Business School
4
-
Harvard Extension School
1
-
Harvard Faculty of Arts and Sciences
1
-
Harvard Graduate School of Arts and Sciences
2
-
Harvard Graduate School of Design
1
-
Harvard Kennedy School
1
-
Harvard Law School
2
-
Harvard Medical School
6
-
Harvard T.H. Chan School of Public Health
2
-
I'm a post-doc
1
-
Non-Harvard Affiliate
3
-
AbscoTx
AbscoTx injects image-guided therapy into tumors to educate the immune system to fight cancer locally and at metastatic sites.
![Absco team]()
-
Aldatu Biosciences
Advancing infectious disease diagnostics that facilitate society's collective response to global health emergencies.
-
Alvus Health INC
Alvus Health is developing a data-centric and automatic platform for target identification and drug discovery.
-
BioDevek
Improving clinical outcomes following internal surgeries using degradable biomaterials.
![Bio Devek team]()
-
Breaking
Breaking Inc. is using synthetic biology to get rid of plastic waste.
![Breaking team]()
-
Ilios Therapeutics
Combating neurodegenerative diseases through rationally-designed multi-functional small molecules.
![Ilios team]()
-
InGel Therapeutics
Regenerative cell-therapy biotech aiming to treat people affected by blindness.
![InGel team]()
-
Kern Systems
Kern Systems is developing cheaper and faster DNA synthesis.
![Kern Systems founder]()
-
Kestrel Therapeutics
Discovering and developing new molecules to treat intractable cancers.
![Kestrel Therapeutics team]()
-
Lightning Biotherapeutics
Sparking immune regeneration by harnessing the body’s inherent regenerative capacity to create novel therapeutics.
-
Manifold Bio
Designing tissue-specific medicines in living systems from the start by combining high-throughput in-vivo studies with AI-guided protein design.
![Manifold team]()
-
Nucyrna Therapeutics
Nucyrna Therapeutics aims to redefine RNA-targeting therapeutics, starting in neurodegenerative diseases.
![Nucyrna team lead]()
-
Promakhos Therapeutics
Developing oral, non-immunosuppressive, small molecules to cure chronic inflammatory disorders.
![promakhos therapeutics team]()
-
Stratagen Bio
Transforming MRI scans into a tool for objective clinical decision-making and quantitative biomarker assessment.
![]()
-
Tectonic Therapeutic, Inc.
Transforming the discovery of novel drugs addressing targets in the GPCR family.
![Tectonic team]()
-
Vaxess Technologies
Developing a novel transdermal patch technology to transform home delivery of therapies and vaccines
